Liminatus Pharma, Inc. Class A Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIMN research report →
About the company
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
- CEO
- Chris Kim
- IPO
- 2025
- Employees
- 3
- HQ
- La Palma, CA, US
Price Chart
- Market Cap
- $3.82M
- P/E
- -0.35
- P/S
- 0.00
- P/B
- -25.53
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 215.73%
- ROIC
- -283.21%
- Revenue
- $0 · 0.00%
- Net Income
- $-10,206,517 · -251.43%
- EPS
- $-0.43 · -7.50%
- Op Income
- $-2,967,812
- FCF YoY
- -221.15%
- 52W High
- $9.38
- 52W Low
- $0.10
- 50D MA
- $0.17
- 200D MA
- $0.66
- Beta
- 0.70
- Avg Volume
- 20.43M
Get TickerSpark's AI analysis on LIMN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 30, 25 | Iris Acquisition Holdings LLC | other | 0 |
| Jul 10, 25 | Lemons II Philip Wayne | other | 0 |
| Jul 10, 25 | Baek Richard JaiHwan | other | 0 |
| Apr 30, 25 | KH Feelux Co., Ltd | other | 0 |
| Apr 30, 25 | Valetudo Therapeutics LLC | other | 0 |
| Apr 30, 25 | Lee Eun Sook | other | 0 |
| Apr 30, 25 | Baek Ji Yeon | other | 0 |
| Apr 30, 25 | Kim Chris | other | 0 |
| Apr 30, 25 | Choi Beom Kyu | other | 0 |
| Apr 30, 25 | Yoo Byong Chul | other | 0 |
Our LIMN coverage
Recent articles, reports, and earnings notes.
No research on LIMN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LIMN report →Similar companies
Peers in the same neighborhood.